CorPhylaxis

Our founders

The scientists behind
the founding discovery.

Cardiovascular biology, computational discovery and industrial genomics—brought together by a team that connects the scientific question to the experiment.

Portrait of the founder and chief executive officer
Cardiovascular physician-scientist
and computational biologist

Founder and Chief Executive Officer

Founder & Chief Executive Officer

He studies the mechanisms that connect heart injury to heart failure. A Research Assistant Professor at Albert Einstein College of Medicine, he brings deep experience in post-infarction remodeling and the structural biology of cardiac repair.

He generated the discovery underlying CorPhylaxis and built its computational discovery layer. His work connects human cardiac data with experimental models, functional phenotyping and spatial readouts to understand which biological processes to change and which to preserve.

His research includes first-authored publications in Circulation, Matrix Biology and AJP–Heart and Circulatory Physiology. He is an author on more than 30 indexed publications.

Selected achievements

  • Top 5, Louis N. and Arnold M. Katz Basic Science Research Prize, American Heart Association Scientific Sessions 2025.
  • Recipient of the American Heart Association Innovative Project Award and an AHA Postdoctoral Fellowship.
  • Founding research connecting cardiac structural safety with cell-state-specific therapeutic discovery.

Scientific expertise

  • Post-infarction remodeling, cardiac repair and heart-failure biology.
  • Microsurgical disease models, serial echocardiography and functional phenotyping.
  • Single-cell and spatial bioinformatics, multimodal computational biology and scientific AI.
Portrait of the founder and chief operating officer
Genomics operations
and spatial biology leader

Founder and Chief Operating Officer

Founder & Chief Operating Officer

She brings industrial expertise in building, managing and scaling genomics operations. As Genomics Operational Manager at SingulOmics, she built and scaled single-cell and spatial workflows through more than five years of research and development.

Her expertise connects target-discovery biology with the teams, processes and laboratory infrastructure required for reproducible science. At CorPhylaxis, that experience supports the generation and extension of the high-resolution datasets at the heart of the company’s discovery engine.

A co-author on the founding Circulation research, she bridges scientific discovery and operational execution, helping turn complex biological questions into coordinated experimental workflows.

Selected achievements

  • Built and scaled single-cell and spatial biology workflows at SingulOmics.
  • More than five years of industrial R&D in genomics workflow development.
  • Co-author on founder-led research published in Circulation.

Operational and scientific expertise

  • Wet-lab operations, workflow development and reproducible execution.
  • Single-cell and spatial transcriptomics from sample to biological readout.
  • Genomics-based target discovery and the integration of computational and experimental teams.

Why CorPhylaxis exists

A scientific mission.
A deeply human reason.

Our chief executive grew up in a rural community in southern Egypt, two hours from the nearest hospital. The experience of seeing heart attacks lead to lasting heart failure shaped his decision to become a physician—and then a researcher.

Research brought the founding team to a problem that demands greater precision: the heart must heal, yet parts of the healing response can also cause harm. CorPhylaxis was founded to translate that distinction into a new direction for therapeutic discovery.

Build the next chapter of cardiac precision with us.

Connect with the founding team about research, strategic partnerships or investment.

Meet with our team